In the following years, several in vitro and in vivo studies established the association of HNPCC-related tumors with low MSI with germline mutations in MSH6, further confirming that mutations in MSH6 alone were not sufficient to cause MSI in CRC cell lines (31, 32). This evidence concerns the gene MSH6 and colorectal carcinoma.